FDA Drug Application (050625) for SANDIMMUNE by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number050625
Product Number001
FormCAPSULE;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB2 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSANDIMMUNE
Active IngredientCYCLOSPORINE



Back to FDA Applications sponsored by NOVARTIS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.